These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 813947)

  • 1. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):816-24. PubMed ID: 813947
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mazindol in the treatment of obese diabetic patients].
    Dolecek R; Reil P; Skarpová O; Závada M
    Vnitr Lek; 1976 Aug; 22(8):798-804. PubMed ID: 788327
    [No Abstract]   [Full Text] [Related]  

  • 3. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG
    Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
    Riesco J; Troncoso G; Costamaillere L; Rodríguez J
    Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
    [No Abstract]   [Full Text] [Related]  

  • 5. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
    Slama G; Selmi A; Hautecouverture M; Tchobroutsky G
    Diabete Metab; 1978 Sep; 4(3):193-9. PubMed ID: 361463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mazindol in the treatment of obesity in diabetics (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1977 Sep; 116(39):1214-7. PubMed ID: 922789
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L
    Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Drugs in obesity.
    Jackson WP; Vinik AI
    S Afr Med J; 1975 May; 49(20):803. PubMed ID: 1098170
    [No Abstract]   [Full Text] [Related]  

  • 9. Maziniol in the treatment of obesity.
    Sedgwick JP
    Practitioner; 1975 Mar; 214(1281):418-20. PubMed ID: 1096123
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial with a nonamphetaminic anoretic].
    Campagnoli M
    Rev Iber Endocrinol; 1976; 23(137):463-83. PubMed ID: 794978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an anorectic agent (Mazindol) on control of obese diabetics.
    Sanders M; Breidahl H
    Med J Aust; 1976 Oct; 2(15):576-7. PubMed ID: 994969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
    Gołebiowska M; Chlebna-Sokół D; Kobierska I; Konopińska A; Małek M; Mastalska A; Zwaigzne-Raczyńska J
    Przegl Lek; 1981; 38(3):355-8. PubMed ID: 7017827
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of the anorectic effect of mazindol and placebo in obesity].
    Tatoń J; Czech A; Koliński P; Podwysocka G
    Pol Tyg Lek; 1979 Dec; 34(50):1967-70. PubMed ID: 395517
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind evaluation of mazindol in refractory obesity.
    Smith RG; Innes JA; Munro JF
    Br Med J; 1975 Aug; 3(5978):284. PubMed ID: 1097046
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mazindol (Teronac) in the treatment of predominant by food-dependent obesity].
    Husmann F
    Med Welt; 1976 Oct; 27(40):1904-8. PubMed ID: 790077
    [No Abstract]   [Full Text] [Related]  

  • 16. [Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].
    Bratusch-Marrain P; Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Jun; 91(13):455-8. PubMed ID: 380178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind trial of mazindol using a very low calorie formula diet.
    Baird IM; Howard AN
    Int J Obes; 1977; 1(3):271-8. PubMed ID: 363631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-centre general practice trial of mazindol in the treatment of obesity.
    Maclay WP; Wallace MG
    Practitioner; 1977 Mar; 218(1305):431-4. PubMed ID: 322112
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)].
    Gołebiowska M; Chlebna-Sokoł D; Mastalska A; Zwaigzne-Raczyńska J
    Przegl Lek; 1981; 38(2):311-4. PubMed ID: 7017826
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
    Defelice EA; Chaykin LB; Cohen A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.